GxP Compliance for Life Sciences Document Management
Let’s jump in and learn:
Main Takeaways
GxP is a family of Good Practice regulations, including GMP, GLP, GCP, GDP, and GVP, enforced by the FDA, EMA, and equivalent regulatory bodies across pharma, biotech, medical device, and food and agriculture companies.
Every GxP record has to satisfy three pillars: accountability, traceability, and data integrity. Inspectors check records against the ALCOA principle: attributable, legible, contemporaneous, original, and accurate.
GxP document control most often breaks down at the boundary with CROs and external partners, where access, watermarking, and audit trails have to extend beyond the internal team.
A GxP-compliant content platform needs role-based access, complete audit trails, and 21 CFR Part 11 e-signature workflows built into the base platform, not bolted on as a separate tool.
AI is able to analyze clinical study reports, summarize regulatory submissions and search past research, but only within a governed environment where access is still permissioned.
What Is GxP?
GxP is designed to protect consumers by requiring safe manufacturing, safe clinical trials and strict research standards in regulated industries. The FDA established the framework in the United States; equivalent standards exist internationally through the EMA and other regulatory bodies.
Common Good Practice standards include:
- GAP: Good Auditing Practice
- GCP: Good Clinical Practice
- GDP: Good Distribution Practice
- GLP: Good Laboratory Practice
- GMP: Good Manufacturing Practice
- GRP: Good Regulatory/Review Practice
- GSP: Good Safety/Storage Practice
- GVP: Good Pharmacovigilance Practice
Who GxP Applies To
GxP requirements reach beyond drug manufacturers. Pharmaceutical, medical device, and cosmetics companies fall under GxP directly. Food and agriculture companies do too, largely through the Food Safety Modernization Act of 2011. Any organization supporting a regulated company, such as a CRO, a CDMO, or a lab vendor, inherits GxP obligations through the contracts and data it touches. The FDA, EMA, USDA, and equivalent state and international bodies enforce these standards through inspection and audit.
The Three Pillars of GxP Compliance
GxP compliance rests on three pillars, and inspectors check records against all three during an audit.
Accountability ties every action in the record to a specific person. ISO 9001 and equivalent standards require individual contribution tracking, not a shared or anonymous log.
Traceability lets an inspector reconstruct a product's full history: raw materials, process steps, personnel, equipment, and final disposition, in the order they happened.
Data integrity follows the ALCOA principle. A valid GxP record is attributable to a specific person, legible, recorded contemporaneously, at the time the work happened, not reconstructed later, an original or a true copy, and accurate.
The 5 Ps of GxP
At the operational level, GxP requirements are divided into five categories:
- People: training records, clear role definition, third party certification where required and an escalation path for quality issues
- Procedures: Standard SOPs, reviews on a regular basis, formal tracking of deviations when a process does not go as written
- Products and Materials complete specifications and master formulas for each product
- Premises and Equipment: cleanable production areas, validated equipment and documented calibration schedules
- Processes: documented and validated processes with change control on all changes.
GxP readiness assessments also weigh documentation completeness, environmental health and safety controls, and information security and validation, each requiring its own audit trail, maintenance schedule, and disaster recovery plan.
How Biotech and Pharma Companies Maintain GxP Compliance Across CROs and External Partners
Most GxP document control failures happen at an organizational boundary, not inside a single company's own systems. A sponsor works with a CRO on trial data. A pharma company shares manufacturing process documents with a CDMO. A biotech firm opens a data room to a licensing partner during due diligence. Each handoff is a point where access, audit trails, and data integrity have to extend past the walls of one organization.
CRO and sponsor collaboration needs governed access on both sides, not a shared drive or an email thread. Trial documents, case report forms, and site files should live in one repository where the sponsor controls what each CRO, site, and vendor can see, download, or edit, down to the individual document. When a study closes or a partner's scope ends, revoking access is one account change instead of tracking down every file that was shared.
Role-based access matters just as much inside the company. Early-stage research teams and commercial teams often need different visibility into the same underlying content. A platform limited to company-wide permissions forces firms to duplicate content or build manual workarounds to keep that separation.
Intellectual property protection follows the same logic during M&A due diligence, licensing negotiations, and manufacturing partnerships. An expiring data room that closes automatically at deal close, tracks every view and limits access to specific documents protects proprietary compound and process data without slowing the deal.
How Egnyte Supports GxP-Compliant Document Management
Role-based access control scopes permissions by individual account, not by shared login, across internal teams, CROs, and external partners.
Egnyte's Review and Approval Workflows enable organizations to route regulated documents through review and approval processes within the platform. For Life Sciences GxP environments, workflows can require 21 CFR Part 11-compliant digital signatures and maintain audit records throughout the approval process.
Automated version history eliminates the need for manual file-naming conventions for protocols, SOPs and lab documents. Each save generates a version record. Previous versions can be rolled back without creating more “current” files in the folder.
AI Assistant operates on content stored in Egnyte, with access enforced at query time. Research teams can search past studies and regulatory submissions in natural language, and summarize clinical study reports without the underlying data leaving the governed repository.
Sensitive content classification automatically tags PHI and PII across clinical and research documents. This is a Secure & Govern capability, not part of the base platform.
For document control practices specific to FDA inspections, audit trail depth, SOP lifecycle management, and eTMF completeness, see FDA inspection readiness: a document control checklist for biopharma quality teams.
Frequently Asked Questions
GxP compliance for document workflows comes down to three things: who can access a record, whether every action on it is logged, and whether the record meets ALCOA data integrity requirements. Clinical trial documents need one governed repository, not a mix of shared drives, email attachments, and CRO-managed systems. A sponsor can then demonstrate control over the full trial master file on any given day, before an inspector ever asks.
Role-based permissions, audit trails, and encryption apply to genomic and clinical data files the same way they apply to any other regulated content, plus the storage performance to handle large file sizes without forcing researchers into local copies that fall outside governance. A platform built for large file handling keeps genomic datasets in the governed repository instead of on individual workstations.
Sponsors and CROs work from a shared repository where the sponsor sets access by role, study, and site. Granting broad folder access or emailing files case by case gives up that control. Every document view, download, and edit is logged with the individual's identity. A sponsor can produce a complete access history for any trial document during a regulatory audit, including actions taken by CRO staff outside the sponsor's own organization.
M&A due diligence and licensing negotiation data rooms should control access at the document level (not the folder level), log each view and auto expire when the deal closes or negotiation is over. The same model applies to manufacturing partnerships. A CDMO gets access to the process documents it needs for production, not the full research archive behind them.
A compound's early research data may need to stay restricted even after it moves toward commercialization, while commercial teams need broader access to the same underlying content, specifications and regulatory filings included. Role-based permissions scoped by team and project keep that separation without relying only on company-wide folder structure or duplicating content into parallel copies.
Access to clinical documents containing PHI should be limited to the specific individuals who need it for their role, with every access logged for HIPAA audit purposes. Automated classification can flag PHI and PII across a document repository so sensitive fields get the right handling by default, not through manual review at intake. The same classification approach extends to CPRA and other state and international privacy frameworks that may apply alongside HIPAA, depending on where trial participants are located.
AI Assistant, running inside the governed repository, can summarize clinical study reports, surface relevant findings from past research when scoping new studies, and answer natural-language questions across regulatory submissions without the underlying documents leaving the platform. Access is enforced at the query level, so the AI only surfaces content a given researcher is already authorized to see.
Egnyte has helped more than 23,000 customers with millions of users worldwide for more than a decade.
Egnyte has experts ready to answer your questions. For more than a decade, Egnyte has helped more than 23,000+ customers with millions of users worldwide.
Additional Resources
GxP Compliance for Life Sciences
Support GxP requirements with governed content management.
Quality Management for Life Sciences
Streamline quality processes, reviews, and documentation.
Guide to GxP Document Management
Key considerations for selecting a GxP-compliant platform.